Advertisement

Epidemiology of Age-Related Macular Degeneration

  • Ronald Klein

Keywords

Macular Degeneration Geographic Atrophy Senile Macular Degeneration Neovascular Macular Degeneration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Age-Related Eye Disease Study Research Group (1999) Design implications. AREDS Report No. 1. Control Clin Trials 20: 573–600Google Scholar
  2. Age-Related Eye Disease Study Research Group (2000) Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study. AREDS Report No 3. Ophthalmology 107: 2224–2232Google Scholar
  3. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 119: 1417–1436Google Scholar
  4. Ajani UA, Christen WG, Manson JE, Glynn RJ, Schaumberg D, Buring JE, Hennekens CH (1999) A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol 9: 172–177CrossRefPubMedGoogle Scholar
  5. Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B (2000) Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol 84: 1343–1348CrossRefPubMedGoogle Scholar
  6. Augustin AJ, Dick HB, Offermann I, Schmidt-Erfurth U (2002) The significance of oxidative mechanisms in diseases of the retina. Klin Monatsbl Augenheilkd 219: 631–643CrossRefPubMedGoogle Scholar
  7. Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343: 269–280PubMedGoogle Scholar
  8. Barondes MJ, Pagliarini S, Chisholm IH, Hamilton AM, Bird AC (1992) Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4-year review. Br J Ophthalmol 76: 5–7PubMedGoogle Scholar
  9. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115–134PubMedGoogle Scholar
  10. Bettman JW, Fellows V, Chao P (1958) The effect of cigarette smoking on the intraocular circulation. Arch Ophthalmol 59: 481–488Google Scholar
  11. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, Jong PT de, Klaver CC, Klein BE, Klein R et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367–374PubMedGoogle Scholar
  12. Bischoff PM, Flower RW (1983) High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration. Am J Ophthalmol 96: 398–399PubMedGoogle Scholar
  13. Blair CJ, Ferguson J Jr (1979) Exacerbation of senile macular degeneration following cataract extraction. Am J Ophthalmol 87: 77–83PubMedGoogle Scholar
  14. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N (1986) Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 93: 552–558PubMedGoogle Scholar
  15. Boker T, Fang T, Steinmetz R (1993) Refractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degeneration. Ger J Ophthalmol 2: 10–13PubMedGoogle Scholar
  16. Borger PH, Leeuwen R van, Hulsman CA, Wolfs RC, Kuip DA van der, Hofman A, Jong PT de (2003) Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. Ophthalmology 110: 1292–1296CrossRefPubMedGoogle Scholar
  17. Borges J, Li ZY, Tso MO (1990) Effects of repeated photic exposures on the monkey macula. Arch Ophthalmol 108: 727–733PubMedGoogle Scholar
  18. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR (1989) The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 107: 847–852PubMedGoogle Scholar
  19. Bressler SB, Maguire MG, Bressler NM, Fine SL (1990) Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 108: 1442–1447PubMedGoogle Scholar
  20. Bressler NM, Muñoz B, Maguire MG, Vitale SE, Schein OD, Taylor HR, West SK (1995) Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol 113: 301–308PubMedGoogle Scholar
  21. Bressler SB, Muñoz B, Phillips D, West S, the SEE Project Team (1998) Prevalence of age-related macular degeneration in a population-based study: SEE project (Abstract). Presented at the Macula Society Meeting, Boca Raton, FL, p 86Google Scholar
  22. Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, Bourguignon C, Harpey C, Brault Y, Coste M, Moccatti D, Bourgeois H (1998) Case-control study of the risk factors for age related macular degeneration. France DMLA Study Group. Br J Ophthalmol 82: 996–1002PubMedGoogle Scholar
  23. Chakrabarti S, Prashar S, Sima AAF (1990) Augmented polyol pathway activity and retinal pigment epithelial permeability in the diabetic BB rat. Diabet Res Clin Pract 8: 1–11Google Scholar
  24. Cho E, Hankinson SE, Willett WC, Stampfer MJ, Spiegelman D, Speizer FE, Rimm EB, Seddon JM (2000) Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 118: 681–688PubMedGoogle Scholar
  25. Christen WG Jr (1994) Antioxidants and eye disease. Am J Med 97: 14S–17S; 22S–28SCrossRefPubMedGoogle Scholar
  26. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE (1996) A prospective study of cigarette smoking and risk of age-related macular degeneration in men. J Am Med Assoc 276: 1147–1151CrossRefGoogle Scholar
  27. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, Manson JE, Hennekens CH (2001) Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 119: 1143–1149PubMedGoogle Scholar
  28. Cousins SW, Marin-Castano ME, Espinosa-Heidmann DG, Alexandridou A, Striker L, Elliot S (2003) Female gender, estrogen loss, and sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci 44: 1221–1229CrossRefPubMedGoogle Scholar
  29. Cruickshanks KJ, Klein R, Klein BEK (1993) Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111: 514–518PubMedGoogle Scholar
  30. Cruickshanks KJ, Hamman RF, Klein R, Nondahl DM, Shetterly SM (1997) The prevalence of age-related maculopathy by geographic region and ethnicity: the Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 115: 242–250PubMedGoogle Scholar
  31. Cruickshanks KJ, Klein R, Klein BEK, Nondahl DM (2001) Sunlight and the 5-year incidence of early age-related maculopathy. The Beaver Dam Eye Study. Arch Ophthalmol 119: 246–250PubMedGoogle Scholar
  32. Curcio CA, Millican CL, Bailey T, Kruth HS (2001) Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 42: 265–274PubMedGoogle Scholar
  33. Darzins P, Mitchell P, Heller RF (1997) Sun exposure and age-related macular degeneration. An Australian case-control Study. Ophthalmology 104: 770–776PubMedGoogle Scholar
  34. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L (1998) Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l’Age. Arch Ophthalmol 116: 1031–105PubMedGoogle Scholar
  35. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L (1999) Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l’Age. Arch Ophthalmol 117: 1384–1390PubMedGoogle Scholar
  36. Delcourt C, Carriere I, Ponton-Sanchez A, Fourrey S, Lacroux A, Papoz L; POLA Study Group (2001a) Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l’Age (POLA) Study. Arch Ophthalmol 119: 1463–1468PubMedGoogle Scholar
  37. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH; POLA Study Group (2001b) Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 8: 237–249CrossRefPubMedGoogle Scholar
  38. Dithmar S, Sharara NA, Curcio CA, Le NA, Zhang Y, Brown S, Grossniklaus HE (2001) Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol 119: 1643–1649PubMedGoogle Scholar
  39. Dubina TL, Mints AYa, Zhuk EV (1984) Biological age and its estimation. III. Introduction of a correction to the multiple regression model of biologicalal age in cross-sectional and longitudinal studies. Exp Gerontol 19: 133–143CrossRefPubMedGoogle Scholar
  40. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA (1987) Leukocytes and the risk of ischemic diseases. J Am Med Assoc 257: 2318–2324CrossRefGoogle Scholar
  41. Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20: 227–253CrossRefPubMedGoogle Scholar
  42. The Eye Disease Case-Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110: 1701–1708Google Scholar
  43. The Eye Disease Case-Control Study Group (1993) Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 111: 104–109Google Scholar
  44. Feeney-Burns L, Ellersieck MR (1985) Age-related changes in the ultrastructure of Bruch’s membrane. Am J Ophthalmol 100: 686–697PubMedGoogle Scholar
  45. Ferris FL 3rd (1983) Senile macular degeneration: review of epidemiological features. Am J Epidemiol 118: 132–151PubMedGoogle Scholar
  46. Frank RN, Puklin JE, Stock C, Canter LA (2000) Race, iris color, and age-related macular degeneration. Trans Am Ophthalmol Soc 98: 109–115PubMedGoogle Scholar
  47. Friedman E (1970) Choroidal blood flow. Pressure-flow relationships. Arch Ophthalmol 83: 95–99PubMedGoogle Scholar
  48. Friedman E (2000) The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130: 658–663PubMedGoogle Scholar
  49. Fryczkowski AW, Sato SE, Hodes BL (1988) Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol 20: 299–305PubMedGoogle Scholar
  50. Gass JD (1973) Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90: 206–217PubMedGoogle Scholar
  51. Gensler G, Klein BEK, Klein R, Chew EY, the AREDS Research Group (2004) The effect of cataract surgery on progression to advanced AMD. Abstract Invest Ophthalmol Vis Sci (in press)Google Scholar
  52. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW (1991) Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3: 189–194CrossRefPubMedGoogle Scholar
  53. Gibson JM, Rosenthal AR, Lavery J (1985) A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK 104: 196–203PubMedGoogle Scholar
  54. Gilles MC, Luo W, Chua W, et al. (2001) The efficacy of a single intravitreal injection of triamcinolone for neovascular age-related macular degeneration. One-year results of a randomized clinical trial: IVTAS (abstract). Invest Ophthalmol Vis 42: S522Google Scholar
  55. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO (1988) Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 128: 700–710PubMedGoogle Scholar
  56. Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Beadet AL, Valle D, Sly WS (eds) The metabolic and molecular basis of inherited disease, 8th edn, vol 2. McGraw-Hill, New York, pp 2863–2913Google Scholar
  57. Gorin MB, Breitner JC, De Jong PT, Hageman GS, Klaver CC, Kuehn MH, Seddon JM (1999) The genetics of age-related macular degeneration. Mol Vis 5: 29PubMedGoogle Scholar
  58. Green WR, Enger C (1993) Age-related macular degeneration histopathologic studies. The 1992 Lorenz E Zimmerman Lecture. Ophthalmology 100: 1519–1535PubMedGoogle Scholar
  59. Gregor Z, Bird AC, Chisholm IH (1977) Senile disciform macular degeneration in the second eye. Br J Ophthalmol 61: 141–147PubMedGoogle Scholar
  60. Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM, Ho AC (1998) Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 39: 385–390PubMedGoogle Scholar
  61. Hachicha M, Naccache PH, McColl SR (1995) Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 182: 2019–2025CrossRefPubMedGoogle Scholar
  62. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20: 705–732CrossRefPubMedGoogle Scholar
  63. Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN (2001) Risk of macular degeneration in users of statins: cross sectional study. Br Med J 323: 375–376Google Scholar
  64. Hammond BR Jr, Wooten BR, Snodderly DM (1996) Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vis Res 18: 3003–3009Google Scholar
  65. Hayes KC, Lindsey S, Stephan ZF, Brecker D (1989) Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci 30: 225–232PubMedGoogle Scholar
  66. Heiba IM, Elston RC, Klein BEK, Klein R (1993) Genetic etiology of nuclear cataract: Evidence for a major gene. Am J Med Genet 47: 1208–1214PubMedGoogle Scholar
  67. Heiba IM, Elston RC, Klein BEK, Klein R (1994) Sibling correlations and segregation analysis of age-related maculopathy: The Beaver Dam Eye Study. Genet Epidemiol 11: 51–67CrossRefPubMedGoogle Scholar
  68. Hidayat AA, Fine BS (1985) Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology 92: 512–522PubMedGoogle Scholar
  69. Hirvela H, Luukinen H, Laara E, Sc L, Laatikainen L (1996) Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103: 871–877PubMedGoogle Scholar
  70. Holz FG, Piguet B, Minassian DC, Bird AC, Weale RA (1994a) Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthalmol 117: 19–23PubMedGoogle Scholar
  71. Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm IH, Bird AC (1994b) Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 101: 1522–1528PubMedGoogle Scholar
  72. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL (1983) Senile macular degeneration: a case-control study. Am J Epidemiol 118: 213–227PubMedGoogle Scholar
  73. Hyman L, Schachat AP, He Q, Leske MC (2000) Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 118: 351–358PubMedGoogle Scholar
  74. Jaffe NS (1982) The intracapsular-extracapsular controversy. Aust J Ophthalmol 10: 115–119PubMedGoogle Scholar
  75. Jampol LM, Tielsch J (1992) Race, macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol 110: 1699–1700PubMedGoogle Scholar
  76. Jonasson F, Thordarson K (1987) Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984. Acta Ophthalmol (Suppl) 182: 40–43Google Scholar
  77. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR (1977) The Framingham Eye Study II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 106: 33–41PubMedGoogle Scholar
  78. Katz ML, Parker KR, Handelman GJ, Bramel TL, Dratz EA (1982) Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp Eye Res 34: 339–369CrossRefPubMedGoogle Scholar
  79. Klaver CC, Kliffen M, Duijn CM van, Hofman A, Cruts M, Grobbee DE, Broeckhoven C van, Jong PT de (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63: 200–206 (erratum in Am J Hum Genet 63: 1252)CrossRefPubMedGoogle Scholar
  80. Klaver CC, Assink JJ, Leeuwen R van, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, Jong PT de (2001) Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42: 2237–2241PubMedGoogle Scholar
  81. Klein BE, Klein R (1982) Cataracts and macular degeneration in older Americans. Arch Ophthalmol 100: 571–573PubMedGoogle Scholar
  82. Klein BEK, Klein R, Jensen SC, Ritter LL (1994) Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 92: 289–297PubMedGoogle Scholar
  83. Klein BEK, Klein R, Moss SE (2000) Exposure to diagnostic X-rays and incident age-related eye disease. Ophthalmic Epidemiol 7: 61–65PubMedGoogle Scholar
  84. Klein BEK, Klein R, Lee KE, Jensen SC (2001a) Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 8: 251–262CrossRefPubMedGoogle Scholar
  85. Klein BEK, Klein R, Lee KE, Moore EL, Danforth L (2001b) Risk of incident age-related eye diseases in people with an affected sibling. The Beaver Dam Eye Study. Am J Epidemiol 154: 207–211CrossRefPubMedGoogle Scholar
  86. Klein R (1999) Epidemiology. In: Berger JW, Fine SL, Maguire MG (eds) Age-related macular degeneration. Mosby, St. Louis, pp 31–55Google Scholar
  87. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991a) The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 98: 1128–1134PubMedGoogle Scholar
  88. Klein R, Klein BEK, Linton KL, De Mets DL (1991b) The Beaver Dam Eye Study: visual acuity. Ophthalmology 98: 1310–1315PubMedGoogle Scholar
  89. Klein R, Klein BEK, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99: 933–943PubMedGoogle Scholar
  90. Klein R, Klein BEK, Linton KL, De Mets DL (1993a) The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137: 190–200PubMedGoogle Scholar
  91. Klein R, Klein BEK, Franke T (1993b) The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 100: 406–414PubMedGoogle Scholar
  92. Klein R, Klein BEK, Wang Q, Moss SE (1994a) Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112: 191–196PubMedGoogle Scholar
  93. Klein R, Klein BEK, Jensen SC, Moss SE, Cruickshanks KJ (1994b) The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision. The Beaver Dam Eye Study. Ophthalmology 101: 1969–1979PubMedGoogle Scholar
  94. Klein R, Klein BEK, Moss SE (1995a) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113: 333–339PubMedGoogle Scholar
  95. Klein R, Rowland ML, Harris MI (1995b) Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 102: 371–381PubMedGoogle Scholar
  96. Klein R, Klein BEK, Lee KE (1996) Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology 103: 1169–1178PubMedGoogle Scholar
  97. Klein R, Klein BEK, Jensen SC, Meuer SM (1997) The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 104: 7–21PubMedGoogle Scholar
  98. Klein R, Klein BEK, Moss SE (1998a) Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 147: 103–110PubMedGoogle Scholar
  99. Klein R, Klein BE, Jensen SC, Cruickshanks KJ (1998b) The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 116: 506–513PubMedGoogle Scholar
  100. Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN, Folsom AR, for the Atherosclerosis Risk in Communities Study Investigators (1999a) Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 117: 1203–1210PubMedGoogle Scholar
  101. Klein R, Klein BEK, Cruickshanks KJ (1999b) The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18: 371–389CrossRefPubMedGoogle Scholar
  102. Klein R, Klein BEK, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M (1999c) Age-related maculopathy in a multiracial United States population. The National Health and Nutrition Examination Survey III. Ophthalmology 106: 1056–1065PubMedGoogle Scholar
  103. Klein R, Klein BEK, Lee KE, Cruickshanks KJ, Chappell RJ (2001a) Changes in visual acuity in a population over a 10-year period. The Beaver Dam Eye Study. Ophthalmology 108: 1757–1766PubMedGoogle Scholar
  104. Klein R, Klein BEK, Jensen SC, Cruickshanks KJ, Lee KE, Danforth LG, Tomany SC (2001b) Medication use and the 5-year incidence of early age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol 119: 1354–1359PubMedGoogle Scholar
  105. Klein R, Klein BEK, Jensen SC, Moss SE (2001c) The relation of socioeconomic factors to the incidence of early age-related maculopathy: The Beaver Dam Eye Study. Am J Ophthalmol 132: 128–131PubMedGoogle Scholar
  106. Klein R, Klein BEK, Tomany SC, Meuer SM, Huang GH (2002a) Ten-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 109: 1767–1779PubMedGoogle Scholar
  107. Klein R, Klein BEK, Tomany SC, Moss SE (2002b) The ten-year incidence of age-related maculopathy and smoking and drinking. The Beaver Dam Eye Study. Am J Epidemiol 156: 589–598CrossRefPubMedGoogle Scholar
  108. Klein R, Klein BEK, Wong TY, Tomany SC, Cruickshanks KJ (2002c) The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy. The Beaver Dam Eye Study. Arch Ophthalmol 120: 1551–1558PubMedGoogle Scholar
  109. Klein R, Klein BE, Marino EK, Kuller LH, Furberg C, Burke GL, Hubbard LD (2003a) Early age-related maculopathy in the Cardiovascular Health Study. Ophthalmology 110: 25–33PubMedGoogle Scholar
  110. Klein R, Klein BEK, Tomany SC, Cruickshanks KJ (2003b) The association of cardiovascular disease with long-term incidence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 110: 1273–1280PubMedGoogle Scholar
  111. Klein R, Klein BEK, Tomany SC, Cruickshanks KJ (2003c) Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol 121: 674–678PubMedGoogle Scholar
  112. Klein R, Klein BEK, Tomany SC, Danforth LG, Cruickshanks KJ (2003d) Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 121: 1151–1155PubMedGoogle Scholar
  113. Kleinmann G, Hoffman P, Schechtman E, Pollack A (2002) Microscope-induced retinal phototoxicity in cataract surgery of short duration. Ophthalmology 109: 334–338CrossRefPubMedGoogle Scholar
  114. Kornzweig AL (1977) Changes in the choriocapillaris associated with senile macular degeneration. Ann Ophthalmol 9: 753–756, 759–762PubMedGoogle Scholar
  115. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, Pool J, Colton TL, Ganley JP, Loewenstein JI, Dawber TR (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2,631 adults, 1973–1975. Surv Ophthalmol 24: 335–610PubMedGoogle Scholar
  116. Leeuwen R van, Klaver CC, Vingerling JR, Hofman A, Jong PT de (2003) The risk and natural course of age-related maculopathy: follow-up at 6.5 years in the Rotterdam Study. Arch Ophthalmol 121: 519–526PubMedGoogle Scholar
  117. Leeuwen R van, Tomany SC, Wang JJ, et al. (2004) Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from three continents. OphthalmologyGoogle Scholar
  118. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY (2001) Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 108: 705–710CrossRefPubMedGoogle Scholar
  119. Liu IY, White L, LaCroix AZ (1989) The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 79: 765–769PubMedGoogle Scholar
  120. Lieber CS, Seitz HK, Garro AJ, et al. (1979) Alcohol-related diseases and carcinogenesis. Cancer Res 39: 2863–2886PubMedGoogle Scholar
  121. Lotfi K, Grunwald JE (1991) The effect of caffeine on human macular circulation. Invest Ophthalmol Vis Sci 32: 3028–3032PubMedGoogle Scholar
  122. Macular Photocoagulation Study Group (1993) Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111: 1189–1199Google Scholar
  123. Macular Photocoagulation Study Group (1997) Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 115: 741–747Google Scholar
  124. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 162: 413–425PubMedGoogle Scholar
  125. Maltzman BA, Mulvihill MN, Greenbaum A (1979) Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 11: 1197–1201PubMedGoogle Scholar
  126. Marano CW, Matschinsky FM (1989) Biochemical manifestations of diabetes mellitus in microscopic layers of the cornea and retina. Diabetes Metab Rev 5: 1–15PubMedCrossRefGoogle Scholar
  127. Mares-Perlman JA, Klein R (1999) Diet and age-related macular degeneration. In: Taylor A (ed) Nutritional and environmental influences on the eye. CRC Press, Boca Raton, FL, pp 181–214Google Scholar
  128. Mares-Perlman JA, Brady WE, Klein R, Vanden Langenberg GM, Klein BEK, Palta M (1995) Dietary fat and age-related maculopathy. Arch Ophthalmol 113: 743–748PubMedGoogle Scholar
  129. Marmot MG, Kogevinas M, Elston MA (1987) Social/economic status and disease. Annu Rev Public Health 8: 111–135CrossRefPubMedGoogle Scholar
  130. Martinez GS, Campbell AJ, Reinken J, Allan BC (1982) Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 94: 181–189PubMedGoogle Scholar
  131. McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR (2001) Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust 175: 340PubMedGoogle Scholar
  132. McDonald HR, Irvine AR (1983) Light-induced maculopathy from the operating microscope in extracapsular cataract extraction and intraocular lens implantation. Ophthalmology 90: 945–951PubMedGoogle Scholar
  133. Menon IA, Wakeham DC, Persad MA, Avaria M, Trope GE, Basu PK (1992) Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J Ocul Pharmacol 8: 35–42PubMedCrossRefGoogle Scholar
  134. Miceli MV, Newsome DA (1991) Cultured retinal pigment epithelium cells from donors with type I diabetes show an altered insulin response. Invest Ophthalmol Vis Sci 32: 2847–2853PubMedGoogle Scholar
  135. Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102: 1450–1460PubMedGoogle Scholar
  136. Mitchell P, Smith W, Wang JJ (1998) Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountain Eye Study. Arch Ophthalmol 105: 1359–1363Google Scholar
  137. Mitchell P, Chapman S, Smith W (1999) Smoking is a major cause of blindness. Med J Aust 171: 173–174PubMedGoogle Scholar
  138. Mitchell P, Wang JJ, Foran S, Smith W (2002) Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109: 1092–1097CrossRefPubMedGoogle Scholar
  139. Moss SE, Klein R, Klein BE, Jensen JC, Meuer SM (1998) Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 105: 789–794PubMedGoogle Scholar
  140. Muñoz BE, West SK, Klein R (2003) Prevalence and risk factors for age related macular degeneration in a population based sample of US Hispanics: Proyecto VER (abstract). Presented at the May 2003 ARVO meeting in Ft. Lauderdale, FLGoogle Scholar
  141. Newsome DA, Huh W, Green WR (1987) Bruch’s membrane age-related changes vary by region. Curr Eye Res 6: 1211–1221PubMedGoogle Scholar
  142. Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M (1998) Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J Am Geriatr Soc 46: 1–7PubMedGoogle Scholar
  143. O’Rourke MF (1982) Arterial Function in Health and Disease. Churchill Livingstone, Edinburgh, p 211Google Scholar
  144. Paetkau ME, Boyd TA, Grace M, Bach-Mills J, Winship B (1978) Senile disciform macular degeneration and smoking. Can J Ophthalmol 13: 67–71PubMedGoogle Scholar
  145. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS (2000) The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 214: 289–291CrossRefPubMedGoogle Scholar
  146. Pauleikhoff D, Chen JC, Chisholm IH, Bird AC (1990) Choroidal perfusion abnormality with age-related Bruch’s membrane change. Am J Ophthalmol 109: 211–217PubMedGoogle Scholar
  147. Pauleikhoff D, Wormald RP, Wright L, Wessing A, Bird AC (1992) Macular disease in an elderly population. Ger J Ophthalmol 1: 12–15PubMedGoogle Scholar
  148. Penfold PL, Killingsworth MC, Sarks SH (1986) Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 27: 364–371PubMedGoogle Scholar
  149. Penfold PL, Madigan MC, Gillies MC, Provis JM (2001) Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 20: 385–414CrossRefPubMedGoogle Scholar
  150. Pierscionek BK, Weale RA (1996) Risk factors and ocular senescence. Gerontology 42: 257–269PubMedCrossRefGoogle Scholar
  151. Poirier J, Minnich A, Davignon J (1995) Apolipoprotein E, synaptic plasticity and Alzheimer’s disease. Ann Med 27: 663–670PubMedGoogle Scholar
  152. Pollack A, Marcovich A, Bukelman A, Oliver M (1996) Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 103: 1546–1554PubMedGoogle Scholar
  153. Pollack A, Bukelman A, Zalish M, Leiba H, Oliver M (1998) The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Lasers 29: 286–294PubMedGoogle Scholar
  154. Pryor WA, Hales BJ, Premovic PI, Church DF (1983) The radicals in cigarette tar: their nature and suggested physiological implications. Science 220: 425–427PubMedGoogle Scholar
  155. Rikans LE, Gonzalez LP (1990) Antioxidant protection systems of rat lung after chronic ethanol inhalation. Alcohol Clin Exp Res 14: 872–877PubMedGoogle Scholar
  156. Ritter LL, Klein R, Klein BEK, Mares-Perlman JA, Jensen SC (1995) Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol 120: 190–196PubMedGoogle Scholar
  157. Roberts JE (2001) Ocular phototoxicity. J Photochem Photobiol B 64: 136–143CrossRefPubMedGoogle Scholar
  158. Rohan RM, Fernandez A, Udagawa T, et al. (2000) Genetic heterogeneity of angiogenesis in mice. FASEB J 14: 871–876PubMedGoogle Scholar
  159. Rosenblum ER, Gavaler JS, Van Thiel DH (1989) Lipid peroxidation: a mechanism for alcohol-induced testicular injury. Free Radic Biol Med 7: 569–577CrossRefPubMedGoogle Scholar
  160. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. J Am Med Assoc 288: 321–333Google Scholar
  161. Roy M, Kaiser-Kupfer M (1990) Second eye involvement in age-related macular degeneration: a four-year prospective study. Eye 4: 813–818PubMedGoogle Scholar
  162. Sandberg MA, Tolentino MJ, Miller S, Berson EL, Gaudio AR (1993) Hyperopia and neovascularization in age-related macular degeneration. Ophthalmology 100: 1009–1013PubMedGoogle Scholar
  163. Sarks JP, Sarks SH, Killingsworth MC (1988) Evolution of geographic atrophy of the retinal pigment epithelium. Eye 2: 552–577PubMedGoogle Scholar
  164. Sarks SH (1976) Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 60: 324–341PubMedGoogle Scholar
  165. Sarks SH, Van Driel D, Maxwell L, Killingsworth M (1980) Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc UK 100: 414–422PubMedGoogle Scholar
  166. Sarks SH, Penfold PL, Killingsworth MC, Driel D van (1985) Patterns in macular degeneration. In: Ryan SJ, Dawson AK, Little HL (eds) Retinal diseases. Grune & Stratton, New York, pp 87–93Google Scholar
  167. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY (1995) Features of age-related macular degeneration in a Black population. The Barbados Eye Study Group. Arch Ophthalmol 113: 728–735PubMedGoogle Scholar
  168. Schaft TL van der, Mooy CM, Bruijn WC de, Oron FG, Mulder PG, Jong PT de (1992) Histologic features of the early stages of age-related macular degeneration. Ophthalmology 99: 278–286PubMedGoogle Scholar
  169. Schaft TL van der, Mooy CM, Bruijn WC de, Mulder PG, Pameyer JH, Jong PT de (1994) Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 78: 441–445PubMedGoogle Scholar
  170. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ (2001) Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 119: 1259–1265PubMedGoogle Scholar
  171. Schmidt S, Saunders AM, De La Paz MA, Postel EA, Heinis RM, Agarwal A, Scott WK, Gilbert JR, McDowell JG, Bazyk A, Gass JD, Haines JL, Pericak-Vance MA (2000) Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 6: 287–293PubMedGoogle Scholar
  172. Schultz DW, Klein ML, Humpert A, Majewski J, Schain M, Weleber RG, Ott J, Acott TS (2003) Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 121: 679–683CrossRefPubMedGoogle Scholar
  173. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett WC (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. J Am Med Assoc 272: 1413–1420CrossRefGoogle Scholar
  174. Seddon JM, Willett WC, Speizer FE, Hankinson SE (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. J Am Med Assoc 276: 1147–1151CrossRefGoogle Scholar
  175. Seddon JM, Cote J, Davis N, Rosner B (2003) Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121: 785–792PubMedGoogle Scholar
  176. Shuttleworth GN, Luhishi EA, Harrad RA (1998) Do patients with age-related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol 82: 611–616PubMedCrossRefGoogle Scholar
  177. Smiddy WE, Fine SL (1984) Prognosis of patients with bilateral macular drusen. Ophthalmology 91: 271–277PubMedGoogle Scholar
  178. Smith W, Mitchell P (1996) Alcohol intake and age-related maculopathy. Am J Ophthalmol 122: 743–745PubMedGoogle Scholar
  179. Smith W, Mitchell P, Leeder SR (1996) Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 114: 1518–1523PubMedGoogle Scholar
  180. Smith W, Mitchell P, Wang JJ (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. (Suppl 1) 25: S13–S15Google Scholar
  181. Smith W, Mitchell P, Leeder SR, Wang JJ (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116: 583–587PubMedGoogle Scholar
  182. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, Jong PT de (2001) Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108: 697–704CrossRefPubMedGoogle Scholar
  183. Snow KK, Seddon JM (1999) Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 6: 125–143CrossRefPubMedGoogle Scholar
  184. Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, Kaplan J, Coscas G, Soubrane G (1998) The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125: 353–359PubMedGoogle Scholar
  185. Sparrow JM, Dickinson AJ, Duke AM, Thompson JR, Gibson JM, Rosenthal AR (1997) Seven year follow-up of age-related maculopathy in an elderly British population. Eye 11: 314–324Google Scholar
  186. Sperduto RD, Seigel D (1980) Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 90: 86–91PubMedGoogle Scholar
  187. Sperduto RD, Hiller R, Seigel D (1981) Lens opacities and senile maculopathy. Arch Ophthalmol 99: 1004–1008PubMedGoogle Scholar
  188. Strahlman ER, Fine SL, Hillis A (1983) The second eye of patients with senile macular degeneration. Arch Ophthalmol 101: 1191–1193PubMedGoogle Scholar
  189. Stryker WS, Kaplan LA, Stein EA, Stampfer MJ, Sober A, Willett WC (1988) The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 127: 283–296PubMedGoogle Scholar
  190. Taylor HR, West S, Muñoz B, Rosenthal FS, Bressler SB, Bressler NM (1992) The long-term effect of visible light on the eye. Arch Ophthalmol 110: 99–104PubMedGoogle Scholar
  191. Tielsch JM (1995) Vision problems in the US: a report on blindness and vision impairment in adults aged 40 and older. Prevent Blindness America. Schaumburg, IL, pp 1–20Google Scholar
  192. Tomany SC, Cruickshanks KJ, Klein R, Klein BEK, Knudtson MD (2003) Sunlight and the 10-year incidence of age-related maculopathy. The Beaver Dam Eye Study. Arch OphthalmolGoogle Scholar
  193. Tomany SC, Klein R, Klein BEK (2001) The relation of coffee and caffeine to the 5-year incidence of early age-related maculopathy: The Beaver Dam Eye Study. Am J Ophthalmol 132: 271–273CrossRefPubMedGoogle Scholar
  194. Tomany SC, Wang JJ, Klein R, Mitchell P, Jong PT de, Vingerling JR, Klein BEK, Smith W (2004a) Risk factors for incident age-related macular degeneration: pooled findings from three continents. Ophthalmology (in press)Google Scholar
  195. Tomany SC, Klein R, Klein BEK (2004b) The relationship between iris color, hair color, and skin sun sensitivity to the 10-year incidence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (in press)Google Scholar
  196. Tong L, Lai M, Klein R, Varma R, LALES Group (2003) Prevalence of age-related Maculopathy (ARM) in a population-based cohort of adult Latinos. The Los Angeles Latino Eye Study (LALES) (Abstract). Presented at the 2003 ARVO Meeting in Ft. Lauderdale, FLGoogle Scholar
  197. VanNewKirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA (2000) The prevalence of age-related maculopathy: The Visual Impairment Project. Ophthalmology 107: 1593–1600PubMedGoogle Scholar
  198. Vinding T (1989) Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 67: 609–616Google Scholar
  199. Vinding T (1990) Pigmentation of the eye and hair in relation to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 68: 53–58Google Scholar
  200. Vinding T, Appleyard M, Nyboe J, Jensen G (1992) Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 70: 66–72Google Scholar
  201. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT (1995a) Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142: 404–409PubMedGoogle Scholar
  202. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, Jong PT de (1995b) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205–210PubMedGoogle Scholar
  203. Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, Jong PT de (1995c) Macular degeneration and early menopause: a case control study. Br Med J 310: 1570–1571Google Scholar
  204. Vingerling JR, Hofman A, Grobbee DE, Jong PT de (1996) Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 114: 1193–1196PubMedGoogle Scholar
  205. Vingerling JR, Klaver CC, Hofman A, Jong PT de (1997) Cataract extraction and age-related macular degeneration: The Rotterdam Study. Abstract presented at ARVO S472, Investigative OphthalmologyGoogle Scholar
  206. Vinores SA, Campochiaro PA, May EE, Blaydes SH (1988) Progressive ultrastructural damage and thickening of the basement membrane of the retinal pigment epithelium in spontaneously diabetic BB rats. Exp Eye Res 46: 545–558PubMedGoogle Scholar
  207. Wang JJ, Mitchell P, Smith W (1998) Refractive error and age-related maculopathy: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 39: 2167–2171PubMedGoogle Scholar
  208. Wang JJ, Mitchell PG, Cumming RG, Lim R (1999) Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 6: 317–326CrossRefPubMedGoogle Scholar
  209. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W (2001) Visual impairment, age-related cataract, and mortality. Arch Ophthalmol 119: 1186–1190PubMedGoogle Scholar
  210. Wang JJ, Foran S, Smith W, Mitchell P (2003a) Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121: 658–663CrossRefPubMedGoogle Scholar
  211. Wang JJ, Klein R, Smith W, Klein BEK, Tomany S, Mitchell P (2003b) Cataract surgery and development of age-related macular degeneration in 5 years: pooled findings from the Beaver Dam and Blue Mountains Eye studies. Ophthalmology (in press)Google Scholar
  212. Weiter JJ, Delori FC, Wing GL, Fitch KA (1985) Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol 99: 185–187PubMedGoogle Scholar
  213. Winkler BS, Boulton ME, Gottsch JD, Sternberg P (1999) Oxidative damage and age-related macular degeneration. Mol Vis 5: 32PubMedGoogle Scholar
  214. Wong TY, Klein R, Klein BEK, Tomany SC (2002) Refractive errors and 10-year incidence of age-related maculopathy. Invest Ophthalmol Vis Sci. 43: 2869–2873PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Ronald Klein

There are no affiliations available

Personalised recommendations